The Quest Diagnostics presentation is scheduled to begin at approximately 9:20
A.M. Eastern Time. The public is invited to listen to the live presentation by
telephone by dialing 800-500-0177 in the U.S. and 719-457-2679 from outside the
U.S. After the presentation, a recording will be available for up to four weeks
and may be heard by dialing 800-759-8603 in the U.S. and 402-220-8537 from
outside the U.S.
Quest Diagnostics will release financial results for the third quarter ended
September 30, 2001, after the close of the stock market on October 18, 2001. The
company is currently in a "quiet" period and will discuss results for the third
quarter during a conference call on October 19 at 8:00 A.M. Eastern Time. To
hear a simulcast of the call over the Internet, or a replay, registered analysts
may access StreetEvents at: http://www.streetevents.com and all others may
access the Quest Diagnostics website at: http://www.questdiagnostics.com. In
addition, a replay of the call will also be available from 10 A.M. on October 19
through 5 P.M. on October 22 to investors in the U.S. by dialing 800-754-7906.
Investors outside the U.S. may dial 402-220-0366. No password is required for
either number.
Quest Diagnostics is the nation's leading provider of diagnostic testing,
information and services with $3.4 billion in annual revenues. The company's
diagnostic testing yields information that enables health care professionals and
consumers to make better decisions to improve health. Quest Diagnostics offers
patients and physicians the broadest access to diagnostic testing services
through its national network of approximately 30 full-service laboratories, 150
rapid response laboratories and more than 1,300 patient service centers, where
specimens are collected. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based testing, and is the leader in routine medical
testing, drugs of abuse testing, and non-hospital- based anatomic pathology
testing. Through partnerships with pharmaceutical, biotechnology and information
technology companies, Quest Diagnostics provides support to help speed the
development of health care insights and new therapeutics. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2000 Form 10-K and subsequent filings.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X52768510
CONTACT: Investors - Cathy Doherty, +1-201-393-5030, or Media - Gary
Samuels, +1-201-393-5700, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
http://www.prnewswire.com
Copyright (C) 2001 PR Newswire. All rights reserved.